Skip to content

Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring

Data Driven Behavior Intervention and Medical Outcome Evaluation of Patients' Comprehensive Monitoring

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04966754
Enrollment
1000
Registered
2021-07-19
Start date
2021-08-01
Completion date
2023-11-30
Last updated
2021-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Infection, Metabolic Complication, Metabolic Disturbance, Metabolic Syndrome, Obesity

Keywords

metabolic, diabetes, obesity, infection, complication

Brief summary

During the study, the resuscitation room, general wards and ICU were installed fixed or mobile acquisition devices in the resuscitation room, the emergency department of Peking Union Medical College Hospital, and the collection platform was set up. Patients with acute diseases (infection, diabetes complications, etc.) caused by metabolic syndrome (obesity, diabetes, etc.) were selected after informed consent. All medical intervention behaviors, relevant medical records and medical outcome records within the collection scope of the device platform were collected prospectively . And regular follow-up, guidance of patients with metabolic syndrome control, while collecting all the lifestyle characteristics of patients, some patients with metabolic cabin research, and observe the relevant medical outcomes. After that, all the collected data were coded, and the influence of all lifestyle and medical behavior interventions on patients' medical outcomes was studied by artificial intelligence method.

Interventions

None listed

Sponsors

Peking University
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
Guangzhou Huyun Hospital Management Co., Ltd
CollaboratorUNKNOWN
Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diabetes and / or obesity (BMI\>=28). * Emergency room / emergency ward / EICU; * Be able to understand and agree the research protocol and sign the informed consent

Exclusion criteria

* Pregnant women / lactation period; * The estimated survival time was less than 1 year; * Long term follow-up is not guaranteed; * Failure to comply with the protocol or procedure; * The collection of medical behavior data can not complete the de privacy or label after de privacy; * Other researchers think that it is not suitable for inclusion

Design outcomes

Primary

MeasureTime frameDescription
Rate of metabolic complications6 weeksRelapse of acute metabolic disease, stability of biochemical metabolic indexes (such as glycosylated hemoglobin, BMI)
Complication control3 weeksThe occurrence of metabolic complications, infection and cardiovascular events
Rate of mortality6 months30-day and 90-day mortality. Death due to cardiovascualr complications

Secondary

MeasureTime frameDescription
Total cost of treatment3 weeksLength of stay, length of stay in ICU, ventilator usage time
Quality of life6 monthsDynamic monitoring of quality of life through quality-of-life evaluation chart

Contacts

Primary ContactHuadong Zhu, MD
huadongzhu@hotmail.com13910696435
Backup ContactWei Wang, Master
wangwei00994998@126.com15600994998

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026